$LUNG FUNG GROUP(02290.HK) got in at a grey market price of 6 yuan, it plummeted to 2 yuan, now it's at 3.6 yuan, should I sell or hold?
Lung Fung Group Holdings Limited, through its subsidiaries, sells beauty, health and pharmaceutical products. It offers Chinese and western medicines, health su...
Long Fine Holdings Limited staged a low-open rally in the morning session, closing at HKD 3.72, up 5.08% from the previous close of HKD 3.54. The move was driven by a strong buying wave after an early dip to HKD 3.48, pushing the stock to its intraday high. With a market cap of approximately HKD 1.86 billion, a PE of 6.91x, and an extremely high PB of 40.33x, the market is pricing in strong earnings power. The stock has surged 85.07% from its 52-week low of HKD 2.01 and trades well above its 20-day (HKD 2.901) and 60-day (HKD 2.846) moving averages, with a year-to-date gain of 32.38%. However, it remains 19.13% below the 52-week high of HKD 4.60, suggesting potential resistance from profit-taking.
Lung Fung Group opened 5.2% higher and sustained its upward momentum, closing the morning session at HK$3.640, up 5.2% and hitting an intraday high. The company's FY26 annual results revealed record revenue of HK$3.28 billion, up 33.2% YoY, and net profit of HK$269.1 million, a 57.9% YoY surge, which underpinned today's rally. The stock is still trading 20.87% below its 52-week high of HK$4.60, yet has gained 29.54% YTD and sits above both its 20-day (HK$2.755) and 60-day (HK$2.750) moving averages. Trading volume was light at 143,500 shares, however, implying a turnover rate of just 0.03%.
Lung Fung Group opened 5.4% lower in the morning session and continued to decline, reaching HKD 3.51 at 10:26 BJ, down 5.1% from the opening price of HKD 3.70, hitting an intraday low of HKD 3.51 with thin trading volume of 579,500 shares. Despite the company's record FY26 annual results released on July 6, with revenue up 33.2% to HKD 3.28 billion and net profit surging 57.9% to HKD 269.1 million, the stock has failed to sustain gains after a sharp post-IPO correction. The current PE of 6.52x and PB of 38.05x reflect a market cap of approximately HKD 1.755 billion, with the stock trading just above its 52-week low of HKD 2.23 and still well below the IPO price.
Longfeng Group Holdings opened higher and closed at HK$3.74, up 5.95%, driven largely by strong year-to-date price performance. The stock hit an intraday low of HK$3.45 before steadily climbing, reaching a high of HK$3.80 in the afternoon session, and eventually settling at HK$3.71, comfortably above both its 20-day moving average (HK$2.685) and 60-day moving average (HK$2.679). Year-to-date gains stand at 33.1%, and while the current price remains 18.7% below the 52-week high of HK$4.6, it has surged 86.07% from the 52-week low of HK$2.01. The company's market capitalization is approximately HK$1.87 billion, with a P/E of 6.95x and a P/B of 40.55x. In the absence of fresh earnings or news catalysts, the rally appears tied to a broader sector re-rating for retail plays, though turnover of about HK$16.75 million and a turnover rate of 0.91% suggest relatively moderate trading activity.
Lung Fung Group staged a sharp reversal after opening lower, driven by recent record annual profit results and subsequent rally news. The stock hit an intraday low of HKD 3.06 in the morning session before recovering gradually, then accelerated in the afternoon to a high of HKD 3.76, closing at HKD 3.60, up 10.8% from the previous close of HKD 3.25. The company earlier reported FY26 annual revenue of HKD 3.28 billion and net profit of HKD 269.1 million, up 33.2% and 57.9% YoY respectively, both record highs. After retreating from its 52-week high of HKD 4.60 on June 4, the stock has rebounded strongly. The current price is 79.1% above the 52-week low of HKD 2.01 and has gained 28.11% YTD, though still 21.74% below the 52-week high. However, the stock faced high volatility, having dropped 16.6% on its debut day.
Lung Fung Group corrects director committee assignments after listing error
Lung Fung Posts Strong Annual Numbers
Independent non-executive director Zhu Huanming increased his holdings in LUNG FUNG GROUP by 4,000 shares at a price of HKD 2.45 per share
Bonjour Hold surged nearly 1.5 times, while the newly listed Lung Fung Group continued to rise by 9%
Lung Fung Group surges 10% on strong annual profit growth
LUNG FUNG GROUP: End of price stabilization period, no price stabilization actions, and expiration of over-allotment rights
$LUNG FUNG GROUP(02290.HK) got in at a grey market price of 6 yuan, it plummeted to 2 yuan, now it's at 3.6 yuan, should I sell or hold?

$LUNG FUNG GROUP(02290.HK) is really a company that's going under, falling every day, already halved.

LUNG FUNG GROUP
HK02290
Subscribing at 4000 times oversubscription doesn't necessarily make money, but subscribing at less than 100 times oversubscription is definitely a loss. The 6000-times-oversubscribed Uisee Technology and the 4000-times-oversubscribed Longfeng Group were my biggest pitfalls in a year of subscribing.
